Effects of COVID-19 vaccination and previous infection on Omicron SARS-CoV-2 infection and relation with serology

Abstract An increasing proportion of the population has acquired immunity through COVID-19 vaccination and previous SARS-CoV-2 infection, i.e., hybrid immunity, possibly affecting the risk of new infection. We aim to estimate the protective effect of previous infections and vaccinations on SARS-CoV-...

Full description

Bibliographic Details
Main Authors: Brechje de Gier, Anne J. Huiberts, Christina E. Hoeve, Gerco den Hartog, Henri van Werkhoven, Rob van Binnendijk, Susan J. M. Hahné, Hester E. de Melker, Susan van den Hof, Mirjam J. Knol
Format: Article
Language:English
Published: Nature Portfolio 2023-08-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-023-40195-z
_version_ 1797558462487461888
author Brechje de Gier
Anne J. Huiberts
Christina E. Hoeve
Gerco den Hartog
Henri van Werkhoven
Rob van Binnendijk
Susan J. M. Hahné
Hester E. de Melker
Susan van den Hof
Mirjam J. Knol
author_facet Brechje de Gier
Anne J. Huiberts
Christina E. Hoeve
Gerco den Hartog
Henri van Werkhoven
Rob van Binnendijk
Susan J. M. Hahné
Hester E. de Melker
Susan van den Hof
Mirjam J. Knol
author_sort Brechje de Gier
collection DOAJ
description Abstract An increasing proportion of the population has acquired immunity through COVID-19 vaccination and previous SARS-CoV-2 infection, i.e., hybrid immunity, possibly affecting the risk of new infection. We aim to estimate the protective effect of previous infections and vaccinations on SARS-CoV-2 Omicron infection, using data from 43,257 adult participants in a prospective community-based cohort study in the Netherlands, collected between 10 January 2022 and 1 September 2022. Our results show that, for participants with 2, 3 or 4 prior immunizing events (vaccination or previous infection), hybrid immunity is more protective against infection with SARS-CoV-2 Omicron than vaccine-induced immunity, up to at least 30 weeks after the last immunizing event. Differences in risk of infection are partly explained by differences in anti-Spike RBD (S) antibody concentration, which is associated with risk of infection in a dose-response manner. Among participants with hybrid immunity, with one previous pre-Omicron infection, we do not observe a relevant difference in risk of Omicron infection by sequence of vaccination(s) and infection. Additional immunizing events increase the protection against infection, but not above the level of the first weeks after the previous event.
first_indexed 2024-03-10T17:30:47Z
format Article
id doaj.art-88c2a47cb73b465283b1375a636466cc
institution Directory Open Access Journal
issn 2041-1723
language English
last_indexed 2024-03-10T17:30:47Z
publishDate 2023-08-01
publisher Nature Portfolio
record_format Article
series Nature Communications
spelling doaj.art-88c2a47cb73b465283b1375a636466cc2023-11-20T10:01:23ZengNature PortfolioNature Communications2041-17232023-08-011411710.1038/s41467-023-40195-zEffects of COVID-19 vaccination and previous infection on Omicron SARS-CoV-2 infection and relation with serologyBrechje de Gier0Anne J. Huiberts1Christina E. Hoeve2Gerco den Hartog3Henri van Werkhoven4Rob van Binnendijk5Susan J. M. Hahné6Hester E. de Melker7Susan van den Hof8Mirjam J. Knol9Center for Infectious Disease Control, National Institute for Public Health and the EnvironmentCenter for Infectious Disease Control, National Institute for Public Health and the EnvironmentCenter for Infectious Disease Control, National Institute for Public Health and the EnvironmentCenter for Infectious Disease Control, National Institute for Public Health and the EnvironmentCenter for Infectious Disease Control, National Institute for Public Health and the EnvironmentCenter for Infectious Disease Control, National Institute for Public Health and the EnvironmentCenter for Infectious Disease Control, National Institute for Public Health and the EnvironmentCenter for Infectious Disease Control, National Institute for Public Health and the EnvironmentCenter for Infectious Disease Control, National Institute for Public Health and the EnvironmentCenter for Infectious Disease Control, National Institute for Public Health and the EnvironmentAbstract An increasing proportion of the population has acquired immunity through COVID-19 vaccination and previous SARS-CoV-2 infection, i.e., hybrid immunity, possibly affecting the risk of new infection. We aim to estimate the protective effect of previous infections and vaccinations on SARS-CoV-2 Omicron infection, using data from 43,257 adult participants in a prospective community-based cohort study in the Netherlands, collected between 10 January 2022 and 1 September 2022. Our results show that, for participants with 2, 3 or 4 prior immunizing events (vaccination or previous infection), hybrid immunity is more protective against infection with SARS-CoV-2 Omicron than vaccine-induced immunity, up to at least 30 weeks after the last immunizing event. Differences in risk of infection are partly explained by differences in anti-Spike RBD (S) antibody concentration, which is associated with risk of infection in a dose-response manner. Among participants with hybrid immunity, with one previous pre-Omicron infection, we do not observe a relevant difference in risk of Omicron infection by sequence of vaccination(s) and infection. Additional immunizing events increase the protection against infection, but not above the level of the first weeks after the previous event.https://doi.org/10.1038/s41467-023-40195-z
spellingShingle Brechje de Gier
Anne J. Huiberts
Christina E. Hoeve
Gerco den Hartog
Henri van Werkhoven
Rob van Binnendijk
Susan J. M. Hahné
Hester E. de Melker
Susan van den Hof
Mirjam J. Knol
Effects of COVID-19 vaccination and previous infection on Omicron SARS-CoV-2 infection and relation with serology
Nature Communications
title Effects of COVID-19 vaccination and previous infection on Omicron SARS-CoV-2 infection and relation with serology
title_full Effects of COVID-19 vaccination and previous infection on Omicron SARS-CoV-2 infection and relation with serology
title_fullStr Effects of COVID-19 vaccination and previous infection on Omicron SARS-CoV-2 infection and relation with serology
title_full_unstemmed Effects of COVID-19 vaccination and previous infection on Omicron SARS-CoV-2 infection and relation with serology
title_short Effects of COVID-19 vaccination and previous infection on Omicron SARS-CoV-2 infection and relation with serology
title_sort effects of covid 19 vaccination and previous infection on omicron sars cov 2 infection and relation with serology
url https://doi.org/10.1038/s41467-023-40195-z
work_keys_str_mv AT brechjedegier effectsofcovid19vaccinationandpreviousinfectiononomicronsarscov2infectionandrelationwithserology
AT annejhuiberts effectsofcovid19vaccinationandpreviousinfectiononomicronsarscov2infectionandrelationwithserology
AT christinaehoeve effectsofcovid19vaccinationandpreviousinfectiononomicronsarscov2infectionandrelationwithserology
AT gercodenhartog effectsofcovid19vaccinationandpreviousinfectiononomicronsarscov2infectionandrelationwithserology
AT henrivanwerkhoven effectsofcovid19vaccinationandpreviousinfectiononomicronsarscov2infectionandrelationwithserology
AT robvanbinnendijk effectsofcovid19vaccinationandpreviousinfectiononomicronsarscov2infectionandrelationwithserology
AT susanjmhahne effectsofcovid19vaccinationandpreviousinfectiononomicronsarscov2infectionandrelationwithserology
AT hesteredemelker effectsofcovid19vaccinationandpreviousinfectiononomicronsarscov2infectionandrelationwithserology
AT susanvandenhof effectsofcovid19vaccinationandpreviousinfectiononomicronsarscov2infectionandrelationwithserology
AT mirjamjknol effectsofcovid19vaccinationandpreviousinfectiononomicronsarscov2infectionandrelationwithserology